Skip to main content
Lupin Ltd logo

Lupin Ltd — Investor Relations & Filings

Ticker · LUPIN ISIN · INE326A01037 LEI · 335800HHXTESDEE2FC65 BSE.NS Manufacturing
Open in API
Filings indexed 3,182 across all filing types
Latest filing 2021-10-22 Regulatory Filings
Country IN India
Listing BSE.NS LUPIN

About Lupin Ltd

https://www.lupin.com/

Lupin Ltd is a global pharmaceutical organization specializing in the development, manufacturing, and marketing of a comprehensive range of generic and branded formulations, biotechnology products, and active pharmaceutical ingredients. The company holds a significant market position in therapeutic segments such as cardiovascular, diabetology, asthma, pediatrics, gastrointestinal, anti-infectives, and non-steroidal anti-inflammatory drugs. It is notably recognized for its leadership in the anti-tuberculosis medication sector. With a strong emphasis on research and development, Lupin focuses on complex generics, specialty medicines, and biosimilars. The company operates advanced manufacturing facilities and maintains a substantial commercial presence across major global markets, including North America, Europe, and the Asia-Pacific region, delivering affordable and high-quality healthcare solutions.

Recent filings

Filing Released Lang Actions
Press Release
Regulatory Filings Classification · 95% confidence The document is a press release announcing the appointment of Bollywood star Hrithik Roshan as the brand ambassador for Lupin's Ayurvedic energy supplement 'Be One'. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to material events or information. The content is promotional and marketing-related, not a financial report, earnings release, or regulatory filing about financial performance or corporate governance. It does not contain financial data, management discussion, or voting results. It is a regulatory disclosure of a material event (brand ambassador appointment) under SEBI regulations, which fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2021-10-22 English
LupinLife signs Hrithik Roshan as the brand ambassador for Be One, Ayurvedic Energy Supplement.
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Lupin Limited has appointed Bollywood star Hrithik Roshan as the brand ambassador for their Ayurvedic energy supplement product 'Be One'. It is addressed to stock exchanges as a disclosure pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The content focuses on marketing and promotional information rather than financial results, management changes, or regulatory filings. It does not contain financial statements, voting results, or any report publication. The document length is 4406 characters, which is relatively short and typical for a regulatory announcement or press release. Given the nature of the content and the regulatory reference, this fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-22 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a compliance certificate issued under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It details the issuance of duplicate share certificates in lieu of lost certificates. The document is addressed to the stock exchange and includes specific shareholder information and certificate numbers. It is not a financial report, earnings release, or management discussion, but rather a regulatory compliance filing related to share certificates. The document length is short (2312 characters) and it serves as a formal notification to the exchange. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2021-10-21 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document text is very short (617 characters) and contains a table detailing the loss of share certificates under a specific regulation (Reg.39(3)). This is a regulatory announcement related to share certificates, not a financial report or management discussion. It does not contain financial data, management changes, voting results, or other report content. It is a regulatory filing about lost share certificates, which fits best under the Regulatory Filings (RNS) category as a miscellaneous regulatory announcement.
2021-10-21 English
Intimation regarding issue of duplicate share certificates.
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to the Department of Corporate Services at BSE Limited, referencing Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015. It details the issuance of duplicate share certificates in lieu of lost certificates. The content focuses on share certificate replacement and does not contain financial data, earnings, management discussion, or other report types. It is a regulatory announcement related to shareholding documentation compliance. Given the nature and length (1591 characters), it is not a full report but a regulatory filing notifying the exchange of a corporate action related to shares. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-10-21 English
Intimation regarding loss of share certificate.
Regulatory Filings Classification · 95% confidence The document is an intimation under Regulation 39(3) of SEBI (Listing Obligation and Disclosure Requirements), 2015, regarding details of a lost share certificate and a request for stop transfer. It is addressed to the stock exchange and contains details about the shareholder and share certificate numbers. This type of document is a regulatory announcement related to shareholding and compliance but does not constitute a financial report, management information, or other specific filings like annual reports or earnings releases. It is a regulatory filing notifying the exchange of a corporate action related to share certificates. The document length is short and it is not a report itself but a notification. Therefore, the appropriate classification is Regulatory Filings (RNS).
2021-10-21 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.